Drug Manufacturers - Specialty & Generic | Healthcare
Kilitch Drugs (India) Limited engages in the development and operation of pharmaceutical business in India. The company offers parenteral and nasal products, including gastroenterology, non-steroidal anti-inflammatory, anticonvulsant/antiepileptic, anti-inflammatory, anti-malarial, aminoglycoside, antibacterial, anti-hypertensive, anti-infective, antifungals, corticosteroids, diagnostic, sympathomimetic, local anesthetic, neurotonic, uterine stimulant, external preparation, oncology, ophthalmic, and other drugs, as well as vaccines and veterinary products. Its parenteral and nasal products also include iron supplements for the treatment of anemia; and metered nasal drops, as well as Klavmox and Onecef products. The company also provides a range of oral formulations, including tablets, soft gelatin capsules, dry syrup, gripe water, and oral gel, powder, and liquid in the cardiovascular and anti-diabetics areas. In addition, it offers effervescent tablets and powders, such as ROIPAR, DUREGRA, and ROIVIT; and various nutritional products, such as CELTINE. Further, the company provides C-Seal, a topical skin adhesive to hold closely approximated skin edges without marks of sutures and incisions. Additionally, it offers cosmetics and herbal products consisting of a range of oils, creams, lotions, liquids, and paste in skin, personal, and hair care categories, as well as herbal products used in sore throat and prostate problems; and as a supplement for diabetes, obesity, libido, and other conditions. The company also exports its products. Kilitch Drugs (India) Limited was founded in 1978 and is headquartered in Mumbai, India.
Market Cap
7799915520
Current Price
485.0
52 Week Range
299.95 - 499.0
Previous Close
464.3
Open
476.0
Sector
Healthcare
Address
37/39, Ujagar Industrial Estate, Waman Tukaram Patil Marg Deonar, Mumbai, 400088, India
Phone
+91-22612-14100
Fax
+91-22670-31658
Website
https://www.kilitch.com
Day Low
465.5
Day High
487.5
Dividend Yield
PE Ratio
29.181707
Earnings Per Share
16.62
Beta
-0.24
EBITDA
314651008
Book Value
125.879
EPS
Name | Title | Age | Year Born |
---|---|---|---|
Mr. Mukund Prataprai Mehta B.Com., LL.B. | Executive Chairman & MD | 71 | 1953 |
Ms. Mira Bhavin Mehta | Managing Director | 46 | 1978 |
Mr. Bhavin Mukund Mehta B.Pharm. | Whole-time Director | 48 | 1976 |
Mr. Sunil Sureshji Jain | Chief Financial Officer | 41 | 1983 |
Tajouddin Ansari | VP-Marketing & Operation | - | - |
Rajesh Khatri | General Manager - Administration | 49 | 1975 |
Ms. Pushpa Nyoupane | Company Secretary & Compliance Officer | - | - |
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Healthcare • Drug Manufacturers - Specialty & Generic
Find high-momentum stocks with strong forward PE ratios and moderate volatility for aggressive investors.
Explore stocks with high dividend yields and low debt-to-equity ratios for stable income.
Discover large-cap stocks with stable beta for lower volatility and reliable returns.
Find undervalued stocks with reasonable forward PE and market cap for value investors.
Discover stocks with strong 5-year revenue growth trading near their 52-week lows, ideal for long-term investment.
Explore high-beta stocks with significant price movement potential for risk-tolerant investors.
Discover mid to large-cap stocks with strong growth potential and attractive valuations.
Find affordable stocks with consistent dividend payouts for income-focused investors.